Congenital Heart Defects
Maternal Diabetes as a Risk Factor for Congenital Heart Defects in Infants of Diabetic Mothers.
1 other identifier
observational
60
0 countries
N/A
Brief Summary
Describe the relationship between maternal diabetes and congenital heart defects in infants born to diabetic mothers referred to NICU unit \& Outpatient clinics of Assiut University Childeren's hospital.We will compare between 2 groups. Cases will represent infants of diabetic mothers \& Conteols will represent infants of non-diabetic mothers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2023
CompletedFirst Posted
Study publicly available on registry
November 9, 2023
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
ExpectedNovember 9, 2023
November 1, 2023
1.2 years
November 5, 2023
November 5, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Assesment of prevalence of congenital heart defects among infants of diabetic mother compared to that in infants of non-diabetic mothers.
Assesment of prevalence of congenital heart defects among infants of diabetic mother compared to that in infants of non-diabetic mothers.
Baseline
Study Arms (2)
Cases
Infants \& children of diabetic mothers
Controls
Infants \& children of non-diabetic mothers
Eligibility Criteria
Neonates and children of diabetic and non-diabetic mothers
You may qualify if:
- The study will include infants of diabetic mothers and infants of non-diabetic mothers not previously screened for congenital heart defects.
You may not qualify if:
- Other risk factors for congenital heart defects including congenital infections like TORCH infection, teratogenic drugs ( lithium or isotretinoin), , alcohol, or smoking.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Al-Biltagi M, Tolba OA, Rowisha MA, Mahfouz Ael-S, Elewa MA. Speckle tracking and myocardial tissue imaging in infant of diabetic mother with gestational and pregestational diabetes. Pediatr Cardiol. 2015 Feb;36(2):445-53. doi: 10.1007/s00246-014-1033-0. Epub 2014 Oct 7.
PMID: 25287219BACKGROUNDClassification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979 Dec;28(12):1039-57. doi: 10.2337/diab.28.12.1039. No abstract available.
PMID: 510803BACKGROUNDAburawi EH. The burden of congenital heart disease in libya. Libyan J Med. 2006 Sep 8;1(2):120-2. doi: 10.4176/060902. No abstract available.
PMID: 21526009BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- 71515,Assiut
Study Record Dates
First Submitted
November 5, 2023
First Posted
November 9, 2023
Study Start
December 1, 2024
Primary Completion
February 28, 2026
Study Completion (Estimated)
May 31, 2026
Last Updated
November 9, 2023
Record last verified: 2023-11